Clinical study on use of raman spectroscopy device to detect skin cancer | va boston health care | veterans affairs
Clinical study on use of raman spectroscopy device to detect skin cancer | va boston health care | veterans affairs"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
BOSTON , MA — VA Boston and VA Tampa healthcare systems launched a multi-site FDA clinical study with Vita Imaging Inc. Friday, Jan. 24, 2025, to evaluate the effectiveness of Vita Imaging’s
AURA Raman spectroscopy device in the detection of melanoma and other skin cancers. “Veterans are at increased risk for skin cancer,” said Dr. Rebecca Hartman, the study’s principal
investigator, chief of Dermatology at VA Boston Healthcare System and assistant professor of dermatology at Brigham and Women's Hospital and Harvard Medical School. “Raman spectroscopy
is non-invasive and can be used in real-time, which we hope will lead to earlier detection, more precise surgical interventions and ultimately better outcomes with fewer unnecessary
biopsies.” Raman spectroscopy illuminates the skin and analyzes the scattered light to create a molecular fingerprint that can be used to identify and differentiate between different types
of skin cancer and normal skin, as well as precancerous conditions and non-malignant skin disorders. ABOUT VA BOSTON HEALTHCARE SYSTEM VA Boston HCS provides comprehensive health care and
services to more than 60,000 Veterans from the greater Boston area and across New England, including primary care, mental health, vision care, surgery, rehabilitation services, oncology and
diagnostic imaging, as well as emergency services, long-term care and a spinal cord injury unit. ABOUT VITA IMAGING INC. Vita Imaging is a Silicon Valley medical technology company
committed to developing and commercializing physician support systems for the screening and detection of cancer in the skin and internal organs. Photo caption (photo linked below): AURA,
Vita Imaging’s Raman skin cancer detection device, which is pending FDA approval. Its effectiveness in detecting melanoma and other skin cancers is being evaluated in the multi-site FDA
clinical validation study that commenced in January 2025 at VA Boston and VA Tampa healthcare systems. (Photo courtesy of Vita Imaging Inc.)
Trending News
Laurence fox: not the hero we want but the hero we deserve | thearticleLaurence Fox, previously best known for his role in Lewis on ITV, burst onto the political scene with panache last week....
A mega blockbuster space release, and mangalyaan did cost less than many sci-fi hollywood moviesThe News Minute| September 24, 2014| 7.320 pm ISTIndia is at its proudest today. What could make it even more proud?Ther...
Brain health — sleep, stress and moreMemorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...
Humanities of Science | NatureScience since Babylon By PROF. Derek J. de Solla Price. Pp. x + 149. (New Haven, Conn., and London: Yale University Pres...
Acapulco airport closed to commercial flights due to floodingThe Pacific coast resort city of Acapulco, which was devastated by the impact of Hurricane Otis last October, was drench...
Latests News
Clinical study on use of raman spectroscopy device to detect skin cancer | va boston health care | veterans affairsBOSTON , MA — VA Boston and VA Tampa healthcare systems launched a multi-site FDA clinical study with Vita Imaging Inc. ...
Doctor, 4 others indicted in steroids ringSAN FRANCISCO — A sports doctor and four other Californians were indicted on charges of running one of the largest stero...
Would-be burglars attempt break-in at Jane Birkin’s home in ParisWould-be burglars attempt break-in at Jane Birkin’s home in Paris The Anglo-French singer, who rose to fame following he...
https://www.journaldemontreal.com/2023/03/25/vinaigrette-emulsionnee-a-lerable 2023-03-25T00:00:19-04:00 https://www.journaldemontreal.com/2023/03/25/https://www.journaldemontreal.com/2023/03/25/vinaigrette-emulsionnee-a-lerable 2023-03-25T00:00:19-04:00https://www.jour...
@ tws : adaptive tunable rf electronics | rcr wireless newsEditorial Reports Editorial Report: Supporting AI, Using AI: Getting to pervasive intelligence in telecom networks Repor...